Medications for Bowel Movement Disorders
There are several distinct categories of medications for treating bowel movement difficulties, with specific agents recommended based on whether the patient has constipation or diarrhea. 1
Medications for Constipation
First-Line Options:
Fiber supplements - These increase stool bulk and stimulate colonic transit:
Osmotic laxatives - Draw water into the intestinal lumen to soften stool and increase bowel movements:
Stimulant laxatives - Increase intestinal motility:
Second-Line Options:
Secretagogues - Increase intestinal fluid secretion:
Prokinetic agents - Enhance intestinal motility:
Sodium hydrogen exchanger 3 inhibitor:
- Tenapanor - Reduces sodium absorption in the intestine, increasing water content in stool 1
Medications for Diarrhea
First-Line Options:
Antidiarrheals:
Bile acid sequestrants - Bind bile acids in the intestine:
- Cholestyramine, colesevelam, colestipol - Particularly effective for bile acid-induced diarrhea 1
Second-Line Options:
5-HT3 receptor antagonists:
Mixed opioid receptor modulators:
Microbiome modification:
Medications for Abdominal Pain in Bowel Disorders
Antispasmodics:
Neuromodulators:
Treatment Algorithm
For constipation:
- Start with lifestyle modifications (exercise, adequate fluid intake) 1, 5
- Add fiber supplements if tolerated 1, 2
- If inadequate response, add osmotic laxatives (PEG 3350, lactulose) 1
- For refractory cases, add stimulant laxatives or secretagogues 1
- Consider prucalopride for chronic idiopathic constipation not responding to other treatments 3
For diarrhea:
Common Pitfalls and Caveats
- Stimulant laxatives should not be used long-term due to potential for dependency and electrolyte disturbances 1
- Anticholinergic antispasmodics may cause dry mouth, blurred vision, and urinary retention, especially in elderly patients 1
- Eluxadoline is contraindicated in patients with history of pancreatitis, severe liver disease, or biliary obstruction 1
- Prucalopride requires dose adjustment in severe renal impairment and should be avoided in end-stage renal disease 3
- Neuromodulators (TCAs, SSRIs) may take 4-6 weeks to show full effect for bowel symptoms 1
- Patients with defecatory disorders may not respond to conventional laxatives and may require biofeedback therapy 6, 7